Provided by Tiger Trade Technology Pte. Ltd.

3SBIO

21.720
-0.620-2.78%
Volume:18.41M
Turnover:409.91M
Market Cap:55.13B
PE:25.55
High:23.100
Open:22.500
Low:21.500
Close:22.340
52wk High:36.800
52wk Low:9.642
Shares:2.54B
HK Float Shares:2.54B
Volume Ratio:0.84
T/O Rate:0.73%
Dividend:0.25
Dividend Rate:1.15%
EPS(LYR):0.850
ROE:13.95%
ROA:6.19%
PB:2.99
PE(LYR):25.55
PS:5.37

Loading ...

HK Stock Movement | 3SBIO (01530) Rises Over 7% in Early Trading as It Plans to Spin Off Subsidiary Mindy International for Separate Listing

Stock News
·
Nov 24, 2025

HK Movers|Biotech Shares Gained. 3SBio And Hengrui Pharma Up 5%; Tigermed Up 3%; SKB Bio, JW Therap, Remegen And Wuxi XDC Up 2%

Tiger Newspress
·
Nov 24, 2025

BUZZ-3SBio drops most in seven months on unit spin-off plans

Reuters
·
Nov 21, 2025

3SBio Proposes Spinoff, Hong Kong Listing of Unit Mandi

MT Newswires Live
·
Nov 21, 2025

China's Largest Minoxidil Brand "Mindy" Eyes Hong Kong IPO, Backed by 340 Million Hair Loss Sufferers

Deep News
·
Nov 21, 2025

BRIEF-3Sbio Proposes Spin-Off And Listing Of Mandi Inc. On HKSE

Reuters
·
Nov 20, 2025

3SBIO (01530) Proposes Spin-off of Mandi International for Separate Listing on HKEX Main Board

Stock News
·
Nov 20, 2025

3SBio - to Cease Holding Interest in Mandi Post Spin-off

THOMSON REUTERS
·
Nov 20, 2025

3SBio - Proposes Spin-off and Listing of Mandi Inc. on Hkse

THOMSON REUTERS
·
Nov 20, 2025

CMSC Initiates Coverage on 3SBIO (01530) with "Strong Buy" Rating, Citing PD-1/VEGF Bispecific Antibody as Catalyst for Revaluation

Stock News
·
Nov 20, 2025

China Universal Asset Management Reduces Stake in 3SBIO (01530) by 1.59 Million Shares at HK$30.55 per Share

Stock News
·
Nov 17, 2025

HK Stock Movement | 3SBIO (01530) Rises Nearly 5% Again as Institutions Note Pfizer's 707 Global Clinical Progress Exceeds Market Expectations

Stock News
·
Nov 14, 2025

Active Southbound Stock Connect Trading on November 13

Stock News
·
Nov 13, 2025

HK Stock Movement | 3SBIO (01530) Surges Over 6% as Pfizer Designates 707 as Core Pipeline, Plans Multiple Clinical Studies

Stock News
·
Nov 13, 2025

HK Movers | Biomedical Stocks Jump With BeOne Medicines and Biocytogen up 7%

Tiger Newspress
·
Nov 13, 2025

CMB International: Healthcare Sector Favors Stable Strategies, Opportunities in Undervalued Stocks

Stock News
·
Nov 10, 2025

3SBio Inc. (01530) Announces Monthly Return on Movements of Securities for October 2025

Bulletin Express
·
Nov 04, 2025

Insiders Of 3SBio Retain CN¥7.6m Of Investment Selling At Higher Prices

Simply Wall St.
·
Nov 03, 2025

HK Movers|Biotech Shares Soar. 3SBIO up 11%; RemeGen up 8%; SKB BIO up 7%; Junshi Bio up 5%; Hengrui Pharma and Innocare up 4%.

Tiger Newspress
·
Oct 31, 2025

HK Movers|3SBIO Rises 8% in Early Trading as Pfizer Initiates Two Global Phase III Trials for SSGJ-707

Stock News
·
Oct 31, 2025